GoodRx (GDRX)
(Delayed Data from NSDQ)
$6.88 USD
-0.18 (-2.55%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $6.89 +0.01 (0.15%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.88 USD
-0.18 (-2.55%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $6.89 +0.01 (0.15%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Zacks News
AMN or GDRX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMN vs. GDRX: Which Stock Is the Better Value Option?
AMN vs. GDRX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AMN vs. GDRX: Which Stock Is the Better Value Option?
AMN or GDRX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMN vs. GDRX: Which Stock Is the Better Value Option?
GoodRx Holdings, Inc. (GDRX) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
GoodRx Holdings, Inc. (GDRX) delivered earnings and revenue surprises of -10% and 1.57%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
GoodRx Holdings, Inc. (GDRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
GoodRx Holdings, Inc. (GDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMN vs. GDRX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AMN vs. GDRX: Which Stock Is the Better Value Option?
GoodRx Holdings, Inc. (GDRX) Surges 5.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
GoodRx Holdings, Inc. (GDRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
MODV vs. GDRX: Which Stock Is the Better Value Option?
by Zacks Equity Research
MODV vs. GDRX: Which Stock Is the Better Value Option?
GoodRx Holdings, Inc. (GDRX) Q3 Earnings Top Estimates
by Zacks Equity Research
GoodRx Holdings, Inc. (GDRX) delivered earnings and revenue surprises of 12.50% and -0.50%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
AMN vs. GDRX: Which Stock Is the Better Value Option?
by Zacks Equity Research
AMN vs. GDRX: Which Stock Is the Better Value Option?
Earnings Preview: GoodRx Holdings, Inc. (GDRX) Q3 Earnings Expected to Decline
by Zacks Equity Research
GoodRx Holdings, Inc. (GDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMN or GDRX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AMN vs. GDRX: Which Stock Is the Better Value Option?
It's Time to Break Up With These 4 Toxic Stocks
by Rimmi Singhi
Identifying toxic stocks and getting rid of them at the right time is the key to guard your portfolio from big losses.
MODV vs. GDRX: Which Stock Is the Better Value Option?
by Zacks Equity Research
MODV vs. GDRX: Which Stock Is the Better Value Option?
MODV vs. GDRX: Which Stock Is the Better Value Option?
by Zacks Equity Research
MODV vs. GDRX: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights: GoodRx Holdings, American Well Corp, Accolade, SOC Telemed and Teladoc
by Zacks Equity Research
The Zacks Analyst Blog Highlights: GoodRx Holdings, American Well Corp, Accolade, SOC Telemed and Teladoc
Booming Telehealth Market Lures More IPOs and M&A Deals
by Sapna Bagaria
To make the most of the booming telehealth industry, players are coming up with IPOs and resorting to mergers and acquisitions.
GoodRx (GDRX) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
GoodRx' (GDRX) manufacturer solutions offerings continue to grow at a strong rate, registering record bookings over the past months.
Zacks Industry Outlook Highlights: Avantor, Eurofins Scientific, GoodRx Holdings, Apollo Medical and COMPASS Pathways
by Zacks Equity Research
Zacks Industry Outlook Highlights: Avantor, Eurofins Scientific, GoodRx Holdings, Apollo Medical and COMPASS Pathways
5 Top Medical Services Stocks to Beat COVID-Led Industry Challenges
by Urmimala Biswas
Despite the severe challenges posed by the COVID-19 pandemic, higher demand for telemedicine, digital influence and AI is likely to lend support to the Zacks Medical - Services industry. AVTR, ERFSF, GDRX, AMEH and CMPS are poised to gain.